Infectious Disease Doctors in Carolina, PR Accepting Medicare

4 Infectious Disease doctors found. Showing 1 - 4

Dr. Monica Cespedes Santana, MD Internal Medicine - Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 4735 Ave Isla Verde Apt 5k, Carolina, PR 00979 Phone: 787-342-2784

Jorge L Garib, M.D. Internal Medicine - Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: E12 Calle Malaga, Vistamar Marina Este, Carolina, PR 00983 Phone: 787-752-0639    Fax: 787-721-1684

Gloria E Soto-pillich, MD Internal Medicine - Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 2207 Terrazas Parque Escorial, Carolina, PR 00901 Phone: 787-641-7582    Fax: 787-641-4561

Dr. Mario R. Lopez, MD Internal Medicine - Infectious Disease Medicare: Medicare Enrolled Practice Location: 116-1 Calle 74, Villa Carolina, Carolina, PR 00985 Phone: 787-402-9031    Fax: 866-396-9013

News Archive

Lexicon prices $80,000,000 aggregate principal amount of 5.25% Convertible Senior Notes

Lexicon Pharmaceuticals, Inc. today announced that it has priced its offering of $80,000,000 aggregate principal amount of 5.25% Convertible Senior Notes due 2021 (the "Convertible Notes") in a private offering within the United States.

Botox injections may ease the irritation of tinnitus

A preliminary study indicates that Botox injections may ease the irritation of tinnitus, otherwise know as ringing in the ears, for some patients. Researchers say more study is needed, but initial results are promising.

UCSF scientists identify new way to manipulate immune system from autoimmune diseases

Scientists from UC San Francisco have identified a new way to manipulate the immune system that may keep it from attacking the body-s own molecules in autoimmune diseases such as type 1 diabetes, rheumatoid arthritis and multiple sclerosis.

Jiangsu Yanshen found liable for producing and selling inferior quality products

Simcere Pharmaceutical Group, a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded and proprietary pharmaceuticals in China, today announced that Jiangsu Yanshen Biological Technology Stock Co., Ltd. ("Jiangsu Yanshen"), in which Simcere holds a 52.5% controlling stake, has been found liable for producing and selling inferior quality products by the People's Court of Tianning District, Changzhou City and was sentenced to a fine of RMB4.6 million.

Researchers uncover potential new way to regulate the body's natural immune response

Australian researchers have uncovered a potential new way to regulate the body's natural immune response, offering hope of a simple and effective new treatment for auto-immune diseases.

Read more Medical News

› Verified 7 days ago